Observational Study
Copyright ©The Author(s) 2024.
World J Virol. Mar 25, 2024; 13(1): 89469
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89469
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Hepatitis C-related hepatocellular carcinoma mortality rates per 100000 from 1999 to 2019 globally (World Bank regions). aP value < 0.05, significant trend.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Hepatitis C-related hepatocellular carcinoma mortality rates per 100000 from 1999 to 2019 in East Asia and Pacific region. aP value < 0.05, significant trend.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Hepatitis C-related hepatocellular carcinoma mortality rates per 100000 from 1999 to 2019 in Europe and Central Asia region. aP value < 0.05, significant trend.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Hepatitis C-related hepatocellular carcinoma mortality rates per 100000 from 1999 to 2019 in Latin America and the Caribbean region. aP value < 0.05, significant trend.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Hepatitis C-related hepatocellular carcinoma mortality rates per 100000 from 1999 to 2019 in the Middle East and North Africa region. aP value < 0.05, significant trend.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Hepatitis C-related hepatocellular carcinoma mortality rates per 100,000 from 1999 to 2019 in the North America region. aP value < 0.05, significant trend.
Figure 7
Open in New Tab Full Size Figure Download Figure
Figure 7 Hepatitis C-related hepatocellular carcinoma mortality rates per 100000 from 1999 to 2019 in the South Asia region. aP value < 0.05, significant trend.
Figure 8
Open in New Tab Full Size Figure Download Figure
Figure 8 Hepatitis C-related hepatocellular carcinoma mortality rates per 100000 from 1999 to 2019 in the Sub Saharan African region. aP value < 0.05, significant trend.